Current Therapy in Nephrology

Glomerular Diseases

1. Front Matter

   Pages 1-1

   PDF

2. Therapy of Nephritis: New Strategies

   1. Cell Mediated Immunity in Glomerulonephritis: Prospects for Treatment

      • J. Stewart Cameron

      Pages 3-10

   2. Enzyme Therapy of Experimental Glomerulonephritis

      • Steven N. Emancipator, Michael E. Lamm

      Pages 11-16

   3. DNA Antibodies and Idiotypes

      • D. Isenberg

      Pages 17-21

   4. Reduction of Protein Excretion by Allopurinol in Rats with Adriamycin Nephrosis

      • F. Ginevri, G. M. Ghiggeri, R. Oleggini, G. Candiano, R. Bertelli, F. Perfumo et al.

      Pages 22-24

   5. Clinical Experience with an Antithrombotic Agent (Defibrotide) in Glomerular Diseases. Preliminary Results

      • G. M. Frasca’, B. Stagni, C. Raimondi, A. Vangelista, V. Bonomini

      Pages 25-27

   6. Defibrination with Ancrod in Crescentic Glomerular Lesions: Preliminary Observation

      • J. M. Mauri, R. Poveda, M. T. González, M. Carrera, J. Carreras, C. Díaz et al.

      Pages 28-30

   7. PAF Induced Glomerular and Vascular Alterations in the Isolated Perfused Rat Kidney

      • Ullrich Schwertschlag, Vincent Dennis, Giovanni Camussi

      Pages 31-33

   8. Histogenesis of Glomerular Crescents in Idiopathic Proliferative Extracapillary Glomerulonephritis. Clinical Aspects

      • J. Diez, F. J. Pardo-Mindan

      Pages 34-36

   9. Premises for an Antioxidant Therapy in Pregnancy Induced Nephropathy

      • P. Stratta, C. Canavese, L. Gurioli, M. Porcu, M. Dogliani, F. Belliardo et al.

      Pages 37-39

   10. Pulse Therapy with Cyclophosphamide in Primary and Sistemic Glomerulopathy Resistant to Steroid Treatment

       • D. Grekas, H. Kalekou, G. Karkavelas, L. Settas, P. Alivanis, M. Pyrpasopoulos

       Pages 40-42

3. IgA Nephropathy

   1. Clinical Presentation of IgA Nephropathy in Southern Italy

      • M. Balletta, G. Fuiano, P. Stanziale, M. Viscione, G. Marinelli, A. Sellaro et al.

      Pages 45-48

   2. Interleukin-2 Production and Abnormalities of Immune Regulation in Patients with Primary IgA Nephropathy

      • F. P. Schena, G. Mastrolitti, A. R. Fracasso, L. Aventaggiato

      Pages 49-52

   3. In-Vitro Study of T Lymphocyte Activation in IgA Nephropathy (GN)

      • K. N. Lai, J. C. K. Leung, P. Li, F. M. Lai

      Pages 53-55

   4. HLA Class II Histoglobulins Involvement in Mesangial IgA Glomerulonephritis (Berger’s Disease)

      • A. Volpi, L. Salvaneschi, A. Sessa, M. Martinetti, P. Serbelloni, M. Cuccia Belvedere

      Pages 56-58

   5. Variations in T Lymphocyte Subsets in IgA Nephropathy

      • M. Sanna, R. Pistis, R. Faedda, A. Satta, E. Sulis, G. Serra et al.

      Pages 59-61

   6. Acute Renal Failure (ARF) As Expression of a IqA Nephropathy (IqAN)

      • S. Ciqarrán, J. Avedillo, A. Pereira

      Pages 62-64

   7. Abnormal Intestinal Permeability in IgA Nephropathy

      • C. Pecoraro, M. T. Saravo, P. Stanziale, M. M. Balletta, G. Parrilli, G. Budillon

      Pages 65-67

4. Nephrotic Syndrome

   1. Efficiency and Tolerance of Cyclosporine Treatment in Adult Nephrosis

      • A. Meyrier

      Pages 71-75